UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 4 | April 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 8 Issue 5
May-2021
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2105731


Registration ID:
309566

Page Number

f482-f507

Share This Article


Jetir RMS

Title

Neuroendocrine tumor in lung

Abstract

The majority of neuroendocrine tumeurs in the gastrointestinal tractor and bronchopulmonary system may mature in the human body. The tumours of neuroendocrine are categorised according to the degree of biological aggression (G1–G3) and the degree of differentiation. Typical (G1) and atypical (G2) carcinoids are the well differentiated neoplasms. Largely distinguished neuroendocrine carcinomas in large cells and small cell carcinomas (G3). Identification and distinction of atypical carcinoids or large-cell neuroendocrine carcinomas and small-cell carcinomas in care choices and pronostics is important. The neuroendocrinal pulmonary tumours are distinguished by proportion of necrosis and mitotic activity, palisading, rosetary, trabecular pattern and organic nesting. The information provided on the histopathological evaluation, characterization, prognoses, genetic aberration and treatment options of neuroendocrine pulmonary tumours is based on their own experiences and on an examination of the present literature. In the identity of typical versus atypical carcinoids atypical versus regular, cell neuropheneous, and big neuroendocrine, large cell carcinomas versus small cell carcinomas, there is a majority of differences between classification of neuroendenocrine tumour entities. Of addition, the classification in small biopsies that can be packed into cytological specimens is constrained by the specimen specificity of the immunohistochemical markers and potential objects. To this day, the prevalence of neuroendocrine pulmonary tumours has increased. As compared to NSCLCs, only little research has been done with respect to new molecular targets as well as improving the classification and differential diagnosis of neuroendocrine tumors of the lung.

Key Words

Neuroendocrine tumor in lung and effect in lung

Cite This Article

"Neuroendocrine tumor in lung ", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.8, Issue 5, page no.f482-f507, May-2021, Available :http://www.jetir.org/papers/JETIR2105731.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Neuroendocrine tumor in lung ", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.8, Issue 5, page no. ppf482-f507, May-2021, Available at : http://www.jetir.org/papers/JETIR2105731.pdf

Publication Details

Published Paper ID: JETIR2105731
Registration ID: 309566
Published In: Volume 8 | Issue 5 | Year May-2021
DOI (Digital Object Identifier):
Page No: f482-f507
Country: Amman , Amman , Jordan .
Area: Medical Science
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000503

Print This Page

Current Call For Paper

Jetir RMS